Cargando…

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD

In older adults, chronic obstructive pulmonary disease (COPD) is commonly associated with heart failure with reduced ejection fraction (HFrEF), and the high prevalence of this combination suggests that customized treatment is highly necessary in patients with COPD and HFrEF. To investigate whether t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Mahoto, Komamura, Kazuo, Kitakaze, Masafumi, Hirayama, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871950/ https://www.ncbi.nlm.nih.gov/pubmed/29283405 http://dx.doi.org/10.3390/diseases6010004

Ejemplares similares

Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure
por: Komamura, Kazuo
Publicado: (2013)

Concomitant diastolic dysfunction further interferes with cognitive performance in moderate to severe systolic heart failure
por: Shin, Mi-Seung, et al.
Publicado: (2017)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)

Impact of bronchodilator therapy on exercise tolerance in COPD
por: Aguilaniu, B
Publicado: (2010)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Flow and volume response to bronchodilator in patients with COPD
por: Matteo, Vigna, et al.
Publicado: (2018)

Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure
por: Gal, Roland, et al.
Publicado: (2020)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
por: Strange, Charlie, et al.
Publicado: (2019)

Future concepts in bronchodilation for COPD: dual- versus monotherapy
por: Singh, Dave, et al.
Publicado: (2021)

Stepwise management of COPD: What is next after bronchodilation?
por: Miravitlles, Marc, et al.
Publicado: (2023)

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007)

Advances in systolic heart failure
por: Yuzefpolskaya, Melana, et al.
Publicado: (2010)

Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
por: Richter, Daphne C, et al.
Publicado: (2008)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020)

The Value of Cardiopulmonary Exercise Testing in Determining Severity in Patients with both Systolic Heart Failure and COPD
por: Goulart, Cássia da Luz, et al.
Publicado: (2020)

Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure
por: Imazu, Miki, et al.
Publicado: (2020)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
por: Kim, Victor, et al.
Publicado: (2014)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
por: Pascoe, Steven, et al.
Publicado: (2016)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial
por: Ramírez-Venegas, Alejandra, et al.
Publicado: (2019)

Is it Reasonable to Start Bronchodilator Treatment Before Confirming the Diagnosis of COPD?
por: Figueira-Gonçalves, Juan Marco, et al.
Publicado: (2023)

Echocardiographic evaluation of systolic heart failure
por: Lo, Queenie, et al.
Publicado: (2015)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Bronchodilator response of advanced lung function parameters depending on COPD severity
por: Jarenbäck, Linnea, et al.
Publicado: (2016)

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
por: Neder, José Alberto, et al.
Publicado: (2019)

Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
por: Minakata, Yoshiaki, et al.
Publicado: (2020)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
por: Gong, Shiyi, et al.
Publicado: (2021)

Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
por: Pini, Laura, et al.
Publicado: (2022)

Publisher Correction: The Value of Cardiopulmonary Exercise Testing in Determining Severity in Patients with both Systolic Heart Failure and COPD
por: da Luz Goulart, Cássia, et al.
Publicado: (2020)

Systolic pulmonary regurgitation affects the outcome of patients with severe systolic heart failure
por: Hsiao, Shih‐Hung, et al.
Publicado: (2021)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oh6v2jntspt5a0sj5v8ecrhbuf